203389 Sigma-AldrichInSolution™Blebbistatin, Racemic - Calbiochem
InSolution™Blebbistatin, Racemic, is a 50 mM in 90% DMSO. A cell-permeable, selective, and reversible inhibitor of nonmuscle myosin II. Blocks cell blebbing and disrupts cell migration & cytoKines
More>> InSolution™Blebbistatin, Racemic, is a 50 mM in 90% DMSO. A cell-permeable, selective, and reversible inhibitor of nonmuscle myosin II. Blocks cell blebbing and disrupts cell migration & cytoKinesis. Less<<MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Recommended Products
Overview
Key Spec Table
| Empirical Formula |
|---|
| C₁₈H₁₆N₂O₂ |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 203389-5MG |
|
Plastic ampoule | 5 mg |
|
— |
| Description | |
|---|---|
| Catalogue Number | 203389 |
| Brand Family | Calbiochem® |
| Product Information | |
|---|---|
| ATP Competitive | N |
| Form | Liquid |
| Formulation | A 50 mM (5 mg/342 µl) solution of (±)-Blebbistatin (Cat. No. 203390) in 90% DMSO. |
| Hill Formula | C₁₈H₁₆N₂O₂ |
| Chemical formula | C₁₈H₁₆N₂O₂ |
| Hygroscopic | Hygroscopic |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ100 |
| Biological Information | |
|---|---|
| Primary Target | ATPase |
| Primary Target IC<sub>50</sub> | <100 µM inhibiting the ATPase and gliding motility of human platelets |
| Purity | ≥97% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 203389-5MG | 04055977221251 |